Drug Profile
Meningococcal vaccine recombinant - ID Biomedical
Alternative Names: NspA vaccine; SPD-704Latest Information Update: 21 Jan 2008
Price :
$50
*
At a glance
- Originator ID Biomedical Corporation
- Class
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Meningococcal infections
Most Recent Events
- 08 Dec 2005 ID Biomedical Corporation has been acquired by GlaxoSmithKline
- 21 Sep 2004 Shire Biologics has been acquired and merged into ID Biomedical Corporation
- 25 Jun 2002 This vaccine is still in active development